Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
san diego blog main
san diego top stories
3
×
boston blog main
boston top stories
bristol-myers squibb
clinical trials
fda
national top stories
san francisco blog main
acute myeloid leukemia
adverum biotechnologies
ambit biosciences
athena countouriotis
biotech ipos
boston
boulder/denver blog main
boulder/denver top stories
brett zbar
cancer
cancer immunotherapy
cancer vaccine
chronic kidney disease
cormorant asset management
daiichi sankyo
detroit blog main
detroit top stories
dyne therapeutics
food and drug administration
forty seven
halozyme therapeutics
hbm healthcare investments
hbm partners
indiana blog main
indiana top stories
investing
ipo
jean cui
What
million
3
×
raised
3
×
therapeutics
3
×
drug
ipo
new
athena
biotech
biotechs
brings
cancer
ceo
chief
club
companies
company
continued
countouriotis
crop
developing
disorders
dyne
dyne’s
exceeded
financing
firms
genetic
gets
group
haul
joined
latest
life
medical
medicines
met
mezzanine
momentum
muscle
muscular
Language
unset
Current search:
xconomy.com
×
million
×
" san diego top stories "
×
raised
×
therapeutics
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M